SuperworthNational Vision EPS EYE
Diluted earnings per share by quarter and over the last twelve months, from 2016.
- Last 12 months, to Jul 4, 2026
- $0.61
- Latest quarter, Q2 FY26
- $0.15
- +36% on a year earlier
- Fiscal year 2025
- $0.37
National Vision's earnings per share was $0.61 over the twelve months to Jul 4, 2026.
In its latest quarter, Q2 FY26, it was $0.15, up 36% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 2% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.37 | n/a |
| FY2024 | −$0.36 | n/a |
| FY2023 | −$0.87 | −278% |
| FY2022 | $0.49 | −65% |
| FY2021 | $1.41 | +244% |
| FY2020 | $0.41 | +3% |
| FY2019 | $0.40 | +38% |
| FY2018 | $0.29 | −55% |
| FY2017 | $0.65 | n/a |
| FY2016 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.15 | +36% | $0.61 | |
| Q1 FY26 | $0.38 | +111% | $0.57 | |
| Q4 FY25 | $0.04 | n/a | $0.37 | |
| Q3 FY25 | $0.04 | n/a | −$0.03 | |
| Q2 FY25 | $0.11 | n/a | −$0.18 | |
| Q1 FY25 | $0.18 | +20% | −$0.33 | |
| Q4 FY24 | −$0.36 | n/a | −$0.36 | |
| Q3 FY24 | −$0.11 | n/a | −$0.20 | |
| Q2 FY24 | −$0.04 | −157% | −$1.03 | |
| Q1 FY24 | $0.15 | −25% | −$0.92 | |
| Q4 FY23 | −$0.20 | n/a | −$0.87 | |
| Q3 FY23 | −$0.94 | −727% | −$0.79 |
Against its peers
Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| EYENational Vision | $0.61 | |
| CDRECadre | $0.81 | −14% a year |
| BVSBioventus | $0.77 | |
| STAAStaar Surgical | $0.07 | |
| LMATLemaitre Vascular | $2.85 | +38% a year |
| IRMDIradimed | $1.79 | +10% a year |
| INSPInspire Medical Systems | $4.62 | +166% a year |
| UFPTUFP Technologies | $9.28 | +8% a year |
| ATRCAtriCure | $0.21 | |
| MOVMovado | $1.80 | +137% a year |
| WRBYWarby Parker | $0.07 | |
| Peer median | $1.30 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on National Vision
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.